rolvedon - eflapegrastim - xnst injection, solution
(Eflapegrastim-Xnst)Spectrum Pharmaceuticals, Inc.
Usage: Rolvedon reduces the risk of febrile neutropenia in adults with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. Not indicated for peripheral blood progenitor cell mobilization for stem cell transplantation.